The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta
Article in Journal of Neuroinflammation (August 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Journal of Neuroinflammation (August 2024)
Article in JASA Express Letters (July 2024)
Article in International Journal of Molecular Sciences (June 2024)